AI assistant
Sending…
SOLIGENIX, INC. — Director's Dealing 2014
Dec 10, 2014
35119_dirs_2014-12-10_41ece644-4a23-4b0c-a142-6bcd8a7965ee.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2014-12-05
Reporting Person: Donini Oreola (Senior Vice President and CSO)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $1.56 | 2023-08-14 | Common Stock (40000) | Direct | |
| Stock Option (Right to Buy) | $2.01 | 2023-12-04 | Common Stock (20000) | Direct | |
| Stock Option (Right to Buy) | $1.50 | 2024-12-03 | Common Stock (30000) | Direct |
Footnotes
F1: The stock option is vested as to 10,000 shares and vests as to the remainder at a rate of 2,500 shares on each three (3) month anniversary of August 15, 2013.
F2: The stock option is vested as to 5,000 shares and vests as to the remainder at a rate of 1,250 shares on each three (3) month anniversary of December 5, 2013.
F3: The stock option is vested as to 7,500 shares and vests as to the remainder at a rate of 1,875 shares on each three (3) month anniversary of December 4, 2014.
More from SOLIGENIX, INC.
Regulatory Filings
2026
May 28
Capital/Financing Update
2026
May 28
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Capital/Financing Update
2026
May 8
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3